We are live on
!
Find out more
HCMNY
Howard Capital Management (New York) Portfolio holdings
AUM
$891M
1-Year Est. Return
34.82%
This Fund
S&P 500
This Quarter
Est. Return
+3.07%
1 Year Est. Return
+34.82%
3 Year Est. Return
+76.77%
5 Year Est. Return
+136.83%
10 Year Est. Return
–
AUM
$695M
AUM Growth
+$8.65M
(+1.3%)
Cap. Flow
-$6.72M
Cap. Flow
% of AUM
-0.97%
Top 10 Holdings %
Top 10 Hldgs %
35.52%
Holding
113
New
5
Increased
32
Reduced
45
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$11.8M |
| 2 |
RTN
Raytheon Company
RTN
|
+$7.66M |
| 3 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$717K |
| 4 |
Coca-Cola
KO
|
+$563K |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$524K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$13.4M |
| 2 |
Kimberly-Clark
KMB
|
+$10.7M |
| 3 |
HPP
Hudson Pacific Properties
HPP
|
+$1.56M |
| 4 |
iShares US Technology ETF
IYW
|
+$971K |
| 5 |
Amazon
AMZN
|
+$584K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.37% |
| 2 | Healthcare | 11.29% |
| 3 | Industrials | 10.93% |
| 4 | Communication Services | 10.76% |
| 5 | Financials | 8.03% |
Similar funds
BII
HCM
LCM
DBC
SWM
DK
AVAX
IVA
Howard Capital Management (New York)'s Q2 2018 Portfolio in Review
As of Q2 2018, Howard Capital Management (New York) held 113 positions worth $695M, up 1.3% from $686M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Howard Capital Management (New York)'s Q2 2018 filing shows 5 new, 32 increased, 45 reduced and 5 closed positions. Its largest new stake was Omnicom Group: 3,412 shares worth $260K. The largest sale was iShares Biotechnology ETF, an estimated $13.4M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.
- Howard Capital Management (New York)'s largest Q2 2018 buy was Omnicom Group: 3,412 shares worth $260K.
- Howard Capital Management (New York) added most to State Street SPDR S&P Biotech ETF in Q2 2018, an estimated $11.8M increase.
- Howard Capital Management (New York)'s biggest Q2 2018 reduction was iShares Biotechnology ETF, cutting an estimated $13.4M.
- Howard Capital Management (New York) fully exited Kimberly-Clark in Q2 2018, selling an estimated $10.7M.
- Howard Capital Management (New York)'s ten largest holdings make up 36% of its $695M portfolio in Q2 2018.
- Howard Capital Management (New York) opened 5 new positions and closed 5 in Q2 2018.
- Howard Capital Management (New York)'s portfolio value rose 1.3% quarter-over-quarter to $695M.
Based on Howard Capital Management (New York)'s 13F filing for Q2 2018, filed 19 Jul 2018.